CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
61 hedge funds and large institutions have $57.1M invested in Concert Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
94% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 18
Holders
61
Holding in Top 10
–
Calls
$100K
Puts
$71K
Top Buyers
| 1 | +$323K | |
| 2 | +$310K | |
| 3 | +$286K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$178K |
| 5 |
BlackRock
New York
|
+$163K |
Top Sellers
| 1 | -$803K | |
| 2 | -$502K | |
| 3 | -$450K | |
| 4 |
Morgan Stanley
New York
|
-$446K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$348K |